Drug Shortage Report for BIO-SERTRALINE
| Report ID | 51238 |
| Drug Identification Number | 02445042 |
| Brand name | BIO-SERTRALINE |
| Common or Proper name | SERTRALINE |
| Company Name | BIOMED PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | SERTRALINE |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-06-04 |
| Estimated end date | |
| Actual end date | 2018-12-13 |
| Shortage status | Resolved |
| Updated date | 2018-12-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2018-06-04 | French | Compare |
| v1 | 2018-06-04 | English | Compare |